Hospital-acquired intestinal toxemia botulism in a newly diagnosed adult colon cancer patient.


Journal

Revista do Instituto de Medicina Tropical de Sao Paulo
ISSN: 1678-9946
Titre abrégé: Rev Inst Med Trop Sao Paulo
Pays: Brazil
ID NLM: 7507484

Informations de publication

Date de publication:
12 Sep 2019
Historique:
received: 13 07 2019
accepted: 15 08 2019
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 24 9 2019
Statut: epublish

Résumé

This manuscript reports a case of intestinal toxemia botulism in an adult with recently diagnosed metastatic colon cancer in whom botulism symptoms began 23 days after hospital admission. Representing the rarest form of botulism presentation in clinical practice, this infectious disease may have developed due to a cluster of predisposing factors that favored Clostridium botulinum colonization and the endogenous production of neurotoxins, among which are previous use of broad-spectrum antibiotics and colon changes related to the development of the neoplasia. This case highlights the importance of considering intestinal toxemia botulism in the differential diagnosis of a patient presenting with symmetrical descending flaccid paralysis, since immediate treatment with botulinum antitoxin may improve clinical outcomes.

Identifiants

pubmed: 31531627
pii: S0036-46652019005000506
doi: 10.1590/S1678-9946201961049
pmc: PMC6746195
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49

Références

Clin Infect Dis. 1999 Dec;29(6):1381-7
pubmed: 10585782
Semin Neurol. 2004 Jun;24(2):155-63
pubmed: 15257512
Clin Infect Dis. 2005 Oct 15;41(8):1167-73
pubmed: 16163636
Disaster Med Public Health Prep. 2007 Nov;1(2):122-34
pubmed: 18388640
Clin Infect Dis. 2009 Jun 15;48(12):1674-5
pubmed: 19435432
Emerg Infect Dis. 2012 Jan;18(1):1-6
pubmed: 22257757
Oman J Ophthalmol. 2012 May;5(2):109-11
pubmed: 22993467
Cochrane Database Syst Rev. 2014 Feb 20;(2):CD008123
pubmed: 24558013
Pediatr Rev. 2016 May;37(5):183-92
pubmed: 27139326
Clin Infect Dis. 2017 Dec 27;66(suppl_1):S99-S102
pubmed: 29293935
Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 03;2(3):291-296
pubmed: 30225463
Infect Dis (Lond). 2019 Feb;51(2):91-96
pubmed: 30663916
Toxins (Basel). 2019 Jul 17;11(7):null
pubmed: 31319550
N Engl J Med. 1986 Jul 24;315(4):239-41
pubmed: 3523248
N Engl J Med. 1986 Jul 24;315(4):254-5
pubmed: 3523249

Auteurs

Lucas José Sá da Fonseca (LJSD)

Universidade Federal de Alagoas, Hospital Universitário Professor Alberto Antunes, Unidade de Reumatologia, Maceió, Alagoas, Brazil.
Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Medicina Interna, Belo Horizonte, Minas Gerais, Brazil.

Diogo Couto de Carvalho (DC)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Medicina Interna, Belo Horizonte, Minas Gerais, Brazil.

Helena Providelli de Moraes (HP)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Izabela Dayany França Feitosa (IDF)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Gil Pereira Neto (G)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Rodrigo Vasconcellos Vilela (RV)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Breno Franco Silveira Fernandes (BFS)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Rodrigo Santiago Gomez (RS)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Neurologia, Belo Horizonte, Minas Gerais, Brazil.

Vandack Nobre (V)

Universidade Federal de Minas Gerais, Hospital das Clínicas, Departamento de Medicina Interna, Unidade de Terapia Intensiva, Belo Horizonte, Minas Gerais, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH